FDA
approval
· 2017-10-04
FDA Approved: MIRALAX — Supplemental Application (Bayer HealthCare LLC.)
Summary
FDA approved a supplemental application for Miralax (polyethylene glycol 3350) from Bayer HealthCare LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MIRALAX (POLYETHYLENE GLYCOL 3350)